Swami U, et al. Advanced prostate cancer: treatment advances and future directions. Trends Cancer. 2020;6(8):702–15.
CAS
PubMed
Google Scholar
Siegel RL, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Article
PubMed
Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
PubMed
Google Scholar
Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
PubMed
Google Scholar
Moul JW. The evolving definition of advanced prostate cancer. Rev Urol. 2004;6(Suppl 8):S10.
PubMed Central
PubMed
Google Scholar
Lorenc T, et al. Exosomes in prostate cancer diagnosis, prognosis and therapy. Int J Mol Sci. 2020;21(6):2118.
CAS
PubMed Central
Google Scholar
Ingrosso G, et al. Current therapeutic options in metastatic castration-resistant prostate cancer. Semin Oncol. 2018;45(5–6):303–15.
CAS
PubMed
Google Scholar
Shanmugam MK, et al. Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. Plos One. 2012;7(3):e32476.
CAS
PubMed Central
PubMed
Google Scholar
Jung YY, et al. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J Cell Physiol. 2021;236(7):5253–64.
CAS
PubMed
Google Scholar
Kretschmer A, Tilki D. Biomarkers in prostate cancer - current clinical utility and future perspectives. Crit Rev Oncol Hematol. 2017;120:180–93.
PubMed
Google Scholar
Lu YT, et al. Current status of liquid biopsies for the detection and management of prostate cancer. Cancer Manag Res. 2019;11:5271–91.
CAS
PubMed Central
PubMed
Google Scholar
Htoo KPP, et al. Colorimetric detection of PCA3 in urine for prostate cancer diagnosis using thiol-labeled PCR primer and unmodified gold nanoparticles. Clin Chim Acta. 2019;488:40–9.
CAS
PubMed
Google Scholar
Wu J, et al. Functionalized NIR-II semiconducting polymer nanoparticles for single-cell to whole-organ imaging of PSMA-positive prostate cancer. Small. 2020;16(19):e2001215.
PubMed
Google Scholar
Yamkamon V, et al. Urinary PCA3 detection in prostate cancer by magnetic nanoparticles coupled with colorimetric enzyme-linked oligonucleotide assay. EXCLI J. 2020;19:501–13.
PubMed Central
PubMed
Google Scholar
Zhang J, et al. Nimbolide-induced oxidative stress abrogates STAT3 signaling Cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model. Antioxid Redox Signal. 2016;24(11):575–89.
CAS
PubMed
Google Scholar
Liu Y, et al. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. J Biol Chem. 2019;294(12):4572–82.
CAS
PubMed Central
PubMed
Google Scholar
Zhang J, et al. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer. Apoptosis. 2017;22(1):158–68.
CAS
PubMed
Google Scholar
Ge R, et al. Epigenetic modulations and lineage plasticity in advanced prostate cancer. Ann Oncol. 2020;31(4):470–9.
CAS
PubMed
Google Scholar
Cheng L, Zhang DY. Molecular genetic pathology. New York: Springer Science & Business Media; 2010.
Wang HT, et al. Neuroendocrine prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis—a systematic review and pooled analysis. J Clin Oncol. 2014;32(30):3383–90.
PubMed
Google Scholar
Robinson D, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215–28.
CAS
PubMed Central
PubMed
Google Scholar
Beltran H, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer discovery. 2011;1(6):487–95.
CAS
PubMed Central
PubMed
Google Scholar
Williamson SR, Eble JN, Cheng L. Molecular pathology of kidney tumors, in Molecular Surgical Pathology. New York: Springer; 2013. p. 171–212.
Jiang G, et al. p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis. Oncol Rep. 2020;43(5):1547–57.
CAS
PubMed Central
PubMed
Google Scholar
Ding Y, et al. Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance. Prostate. 2021;81(1):58–71.
CAS
PubMed
Google Scholar
Sikka S, et al. Targeting PPARγ signaling Cascade for the prevention and treatment of prostate Cancer. PPAR Res. 2012;2012:968040.
PubMed Central
PubMed
Google Scholar
Lee JH, et al. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer. Oncotarget. 2017;8(11):17700–11.
PubMed
Google Scholar
Ichimiya T, et al. Autophagy and autophagy-related diseases: a review. Int J Mol Sci. 2020;21(23):8974.
CAS
PubMed Central
Google Scholar
Aventaggiato M, et al. Sirtuins’ control of autophagy and mitophagy in cancer. Pharmacol Ther. 2020;221:107748.
Bhardwaj M, et al. Regulation of autophagy by canonical and non-canonical ER stress responses. Semin Cancer Biol. 2019;66:116-28. Elsevier.
Singh SS, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37(9):1142–58.
CAS
PubMed
Google Scholar
Deng S, et al. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 2019;125(8):1228–46.
PubMed
Google Scholar
De Duve C, et al. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J. 1955;60(4):604–17.
PubMed Central
Google Scholar
Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci. 2012;69(7):1125–36.
CAS
PubMed
Google Scholar
Tasset I, Cuervo AM. Role of chaperone-mediated autophagy in metabolism. FEBS J. 2016;283(13):2403–13.
CAS
PubMed Central
PubMed
Google Scholar
Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct. 2002;27(6):421–9.
PubMed
Google Scholar
Wen X, Klionsky DJ. At a glance: a history of autophagy and cancer. Semin Cancer Biol. 2020;66:3–11.
PubMed
Google Scholar
Gremke N, et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability. Nat Commun. 2020;11(1):4684.
CAS
PubMed Central
PubMed
Google Scholar
Ishaq M, et al. Autophagy in cancer: recent advances and future directions. Semin Cancer Biol. 2020;66:171–81.
PubMed
Google Scholar
Raj S, et al. Molecular mechanisms of interplay between autophagy and metabolism in cancer. Life Sci. 2020;259:118184.
CAS
PubMed
Google Scholar
Tanaka H, et al. Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin. Biochem Biophys Rep. 2020;22:100750.
PubMed Central
PubMed
Google Scholar
Patel SM, et al. Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases. Semin Cancer Biol. 2016;40-41:100–15.
CAS
PubMed
Google Scholar
Hwang ST, et al. Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells. Phytomedicine. 2019;59:152907.
CAS
PubMed
Google Scholar
Tavakol S, et al. Autophagy modulators: mechanistic aspects and drug delivery systems. Biomolecules. 2019;9(10):530.
Bordoloi D, et al. TIPE family of proteins and its implications in different chronic diseases. Int J Mol Sci. 2018;19(10):2974.
Acevo-Rodríguez PS, et al. Autophagy regulation by the translation machinery and its implications in cancer. Front Oncol. 2020;10:322.
PubMed Central
PubMed
Google Scholar
Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349–64.
CAS
PubMed
Google Scholar
Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–15.
CAS
PubMed
Google Scholar
Takahashi Y, et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nat Commun. 2018;9(1):2855.
PubMed Central
PubMed
Google Scholar
Zhang R, et al. Ion channels and transporters in autophagy. Autophagy. 2021:1–20. https://doi.org/10.1080/15548627.2021.1885147.
Liu J, et al. Autophagy-dependent Ferroptosis: machinery and regulation. Cell Chemical Biology. 2020;27(4):420–35.
PubMed Central
PubMed
Google Scholar
Yin Z, et al. The roles of ubiquitin in mediating autophagy. Cells. 2020;9(9):2025.
CAS
PubMed Central
Google Scholar
Benvenuto M, et al. Polyphenol-mediated autophagy in cancer: evidence of in vitro and in vivo studies. Int J Mol Sci. 2020;21(18):6635.
CAS
PubMed Central
Google Scholar
Zhang HM, et al. MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells. Neoplasia. 2020;22(5):220–30.
CAS
PubMed Central
PubMed
Google Scholar
Kong F, et al. Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Int J Biochem Cell Biol. 2020;122:105731.
CAS
PubMed
Google Scholar
Feng X, et al. Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5. Autophagy. 2020:1–20. https://doi.org/10.1080/15548627.2020.1731266.
Li JP, et al. miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer. J Cell Biochem. 2020;121(5–6):3392–405.
CAS
PubMed
Google Scholar
Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; the three main axes of metastasis. Biomed Pharmacother. 2021;133:110909.
CAS
PubMed
Google Scholar
Salimi L, et al. Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells. Cell Biosci. 2020;10:64.
CAS
PubMed Central
PubMed
Google Scholar
Marsh T, Debnath J. Autophagy suppresses breast cancer metastasis by degrading NBR1. Autophagy. 2020;16(6):1164–5.
CAS
PubMed Central
PubMed
Google Scholar
Alizadeh J, et al. Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells. Biochim Biophys Acta Mol Cell Res. 2018;1865(5):749–68.
CAS
PubMed
Google Scholar
de Souza ASC, et al. The role of autophagy in tumor immunology-complex mechanisms that may be explored therapeutically. Front Oncol. 2020;10:603661.
PubMed Central
PubMed
Google Scholar
Chavez-Dominguez R, et al. The double-edge sword of autophagy in Cancer: from tumor suppression to pro-tumor activity. Front Oncol. 2020;10:578418.
PubMed Central
PubMed
Google Scholar
Yamamoto K, et al. Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer. Autophagy. 2020;16(8):1524–5.
CAS
PubMed Central
PubMed
Google Scholar
Hou G, et al. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin. Can J Physiol Pharmacol. 2020;98(7):449–58.
CAS
PubMed
Google Scholar
Zheng X, et al. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells. Aging (Albany NY). 2020;12(16):16390–409.
CAS
Google Scholar
Ueda S, et al. miR-27a ameliorates chemoresistance of breast cancer cells by disruption of reactive oxygen species homeostasis and impairment of autophagy. Lab Investig. 2020;100(6):863–73.
CAS
PubMed
Google Scholar
Gao S, Wang K, Wang X. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells. Neoplasma. 2020;67(4):724–34.
CAS
PubMed
Google Scholar
Zamame Ramirez JA, Romagnoli GG, Kaneno R. Inhibiting autophagy to prevent drug resistance and improve anti-tumor therapy. Life Sci. 2021;265:118745.
CAS
PubMed
Google Scholar
Muscolino E, et al. Herpesviruses induce aggregation and selective autophagy of host signalling proteins NEMO and RIPK1 as an immune-evasion mechanism. Nat Microbiol. 2020;5(2):331–42.
CAS
PubMed
Google Scholar
Ding M, et al. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer. J Exp Clin Cancer Res. 2020;39(1):28.
CAS
PubMed Central
PubMed
Google Scholar
Wadosky KM, et al. Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells. Prostate. 2019;79(2):140–50.
CAS
PubMed
Google Scholar
Blessing AM, et al. Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression. Autophagy. 2017;13(3):506–21.
CAS
PubMed
Google Scholar
Xie CW, et al. Gabarapl1 mediates androgen-regulated autophagy in prostate cancer. Tumour Biol. 2015;36(11):8727–33.
CAS
PubMed
Google Scholar
Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008;8(12):967–75.
CAS
PubMed Central
PubMed
Google Scholar
Young SD, Marshall RS, Hill RP. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A. 1988;85(24):9533–7.
CAS
PubMed Central
PubMed
Google Scholar
Young SD, Hill RP. Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication. Cancer Res. 1990;50(16):5031–8.
CAS
PubMed
Google Scholar
Xia L, et al. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer. Cell Prolif. 2020;53(11):e12918.
CAS
PubMed Central
PubMed
Google Scholar
Fan Y, et al. PLCε regulates metabolism and metastasis signaling via HIF-1α/MEK/ERK pathway in prostate cancer. J Cell Physiol. 2020;235(11):8546–57.
CAS
PubMed
Google Scholar
Ma Z, et al. Targeting hypoxia-inducible factor-1-mediated metastasis for cancer therapy. Antioxid Redox Signal. 2021;34(18):1484-97.
Shanmugam MK, et al. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol. 2017;15(6):503–19.
CAS
PubMed
Google Scholar
Deng M, et al. HIF-1a regulates hypoxia-induced autophagy via translocation of ANKRD37 in colon cancer. Exp Cell Res. 2020;395(1):112175.
CAS
PubMed
Google Scholar
Yu K, et al. HIF1α promotes prostate cancer progression by increasing ATG5 expression. Anim Cells Syst (Seoul). 2019;23(5):326–34.
CAS
Google Scholar
Zhang N, et al. PAX5-induced upregulation of IDH1-AS1 promotes tumor growth in prostate cancer by regulating ATG5-mediated autophagy. Cell Death Dis. 2019;10(10):734.
PubMed Central
PubMed
Google Scholar
Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235–53.
CAS
PubMed Central
PubMed
Google Scholar
Potthoff MJ, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 2012;26(4):312–24.
CAS
PubMed Central
PubMed
Google Scholar
Dai H, et al. FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway. Cell Death Dis. 2021;12(4):303.
CAS
PubMed Central
PubMed
Google Scholar
Mishra P, Chan DC. Metabolic regulation of mitochondrial dynamics. J Cell Biol. 2016;212(4):379–87.
CAS
PubMed Central
PubMed
Google Scholar
Senft D, Ze’ev AR. Regulators of mitochondrial dynamics in cancer. Curr Opin Cell Biol. 2016;39:43–52.
CAS
PubMed Central
PubMed
Google Scholar
Lee YG, et al. Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer. Cancer Lett. 2020;471:72–87.
CAS
PubMed
Google Scholar
Glover DM, et al. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell. 1995;81(1):95–105.
CAS
PubMed
Google Scholar
Zhou H, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20(2):189–93.
CAS
PubMed
Google Scholar
Jones D, et al. Aurora a regulates expression of AR-V7 in models of castrate resistant prostate cancer. Sci Rep. 2017;7:40957.
CAS
PubMed Central
PubMed
Google Scholar
Buschhorn HM, et al. Aurora-a over-expression in high-grade PIN lesions and prostate cancer. Prostate. 2005;64(4):341–6.
CAS
PubMed
Google Scholar
Zhang S, et al. Aurora-a regulates autophagy through the Akt pathway in human prostate cancer. Cancer Biomark. 2017;19(1):27–34.
CAS
PubMed
Google Scholar
You D, et al. KML001 induces apoptosis and Autophagic cell death in prostate Cancer cells via oxidative stress pathway. Plos One. 2015;10(9):e0137589.
PubMed Central
PubMed
Google Scholar
Chopra P, et al. Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics. Expert Opin Investig Drugs. 2010;19(1):27–43.
CAS
PubMed
Google Scholar
Huang H, et al. Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer. Aging (Albany NY). 2020;12(14):14699–717.
CAS
Google Scholar
Dai X, et al. A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma. Oncotarget. 2017;8(8):12831–42.
PubMed Central
PubMed
Google Scholar
Ko JH, et al. 2,5-Dihydroxyacetophenone induces apoptosis of multiple myeloma cells by regulating the MAPK activation pathway. Molecules. 2017;22(7):1157.
Kim C, et al. Formononetin regulates multiple oncogenic signaling cascades and enhances sensitivity to bortezomib in a multiple myeloma mouse model. Biomolecules. 2019;9(7):262.
Tewari D, et al. Targeting activator protein 1 signaling pathway by bioactive natural agents: possible therapeutic strategy for cancer prevention and intervention. Pharmacol Res. 2018;128:366–75.
PubMed
Google Scholar
Zhang P, et al. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation. Nat Commun. 2020;11(1):2487.
CAS
PubMed Central
PubMed
Google Scholar
Wu Q, et al. Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. J Enzyme Inhib Med Chem. 2020;35(1):574–83.
CAS
PubMed Central
PubMed
Google Scholar
Morgan EL, et al. E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer. Cell Death Differ. 2020;28(5):1669-87.
Shishodia S, et al. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol. 2007;74(1):118–30.
CAS
PubMed Central
PubMed
Google Scholar
Arisan ED, et al. Inhibition on JNK mimics silencing of Wnt-11 mediated cellular response in androgen-independent Prostate cancer cells. Biology (Basel). 2020;9(7):142.
Wang Z, et al. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway. Oncotarget. 2017;8(14):22563–80.
PubMed Central
PubMed
Google Scholar
Wang L, et al. Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer. EBioMedicine. 2016;7:50–61.
CAS
PubMed Central
PubMed
Google Scholar
Lin C, et al. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling. Oncogene. 2021;40(9):1690–705.
CAS
PubMed Central
PubMed
Google Scholar
Huang YL, et al. Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells. Cell Signal. 2014;26(3):611–8.
CAS
PubMed
Google Scholar
Zhou R, et al. p300/CBP-associated factor promotes autophagic degradation of δ-catenin through acetylation and decreases prostate cancer tumorigenicity. Sci Rep. 2019;9(1):3351.
PubMed Central
PubMed
Google Scholar
Quan Z, et al. PLCɛ maintains the functionality of AR signaling in prostate cancer via an autophagy-dependent mechanism. Cell Death Dis. 2020;11(8):716.
CAS
PubMed Central
PubMed
Google Scholar
Jiang Q, et al. Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy. J Urol. 2012;188(4):1361–8.
CAS
PubMed
Google Scholar
Fang F, et al. CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells. Oncol Lett. 2015;9(3):1439–43.
PubMed Central
PubMed
Google Scholar
Shanmugam MK, et al. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer. 2011;129(7):1552–63.
CAS
PubMed
Google Scholar
Shanmugam MK, et al. Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis. Front Pharmacol. 2018;9:1294.
CAS
PubMed Central
PubMed
Google Scholar
Loh CY, et al. Signal Transducer and Activator of Transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication. Front Oncol. 2019;9:48.
PubMed Central
PubMed
Google Scholar
Manu KA, et al. Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma. Plos One. 2013;8(3):e57015.
CAS
PubMed Central
PubMed
Google Scholar
Adekoya TO, Richardson RM. Cytokines and chemokines as mediators of prostate cancer metastasis. Int J Mol Sci. 2020;21(12):4449.
CAS
PubMed Central
Google Scholar
Jin JK, Dayyani F, Gallick GE. Steps in prostate cancer progression that lead to bone metastasis. Int J Cancer. 2011;128(11):2545–61.
CAS
PubMed Central
PubMed
Google Scholar
Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18(1–2):43–73.
PubMed Central
PubMed
Google Scholar
Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–18.
PubMed Central
PubMed
Google Scholar
Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–95.
CAS
PubMed
Google Scholar
Ashrafizadeh M, et al. Association of the Epithelial-Mesenchymal Transition (EMT) with cisplatin resistance. Int J Mol Sci. 2020;21(11):4002.
Cheng JT, et al. Insights into biological role of LncRNAs in Epithelial-Mesenchymal Transition. Cells. 2019;8(10):1178.
Ashrafizadeh M, et al. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the metastasis of bladder cancer. Biomolecules. 2020;10(8):1159.
Wen S, et al. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol Cancer. 2020;19(1):171.
CAS
PubMed Central
PubMed
Google Scholar
Buckup M, et al. Plectin is a regulator of prostate cancer growth and metastasis. Oncogene. 2021;40(3):663–76.
CAS
PubMed
Google Scholar
Xiong Y, et al. WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation. Cell Death Dis. 2020;11(7):537.
CAS
PubMed Central
PubMed
Google Scholar
Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591–6.
CAS
PubMed
Google Scholar
Godoy A, et al. Androgen deprivation induces rapid involution and recovery of human prostate vasculature. Am J Physiol Endocrinol Metab. 2011;300(2):E263–75.
CAS
PubMed
Google Scholar
Wang X, et al. Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals. Mol Cancer Ther. 2013;12(6):1026–37.
CAS
PubMed Central
PubMed
Google Scholar
Tomić TT, et al. Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2. Prostate. 2012;72(7):705–12.
PubMed
Google Scholar
Zhao R, et al. Endothelial cells promote metastasis of prostate cancer by enhancing autophagy. J Exp Clin Cancer Res. 2018;37(1):221.
PubMed Central
PubMed
Google Scholar
Liang T, et al. HDAC6-mediated α-tubulin deacetylation suppresses autophagy and enhances motility of podocytes in diabetic nephropathy. J Cell Mol Med. 2020;24(19):11558–72.
CAS
PubMed Central
PubMed
Google Scholar
Jiang X, et al. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6. Prostate. 2018;78(6):426–34.
CAS
PubMed Central
PubMed
Google Scholar
Lee JH, et al. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Pharmacol Res. 2019;150:104504.
CAS
PubMed
Google Scholar
Hwang ST, et al. Corilagin represses epithelial to mesenchymal transition process through modulating Wnt/β-Catenin signaling cascade. Biomolecules. 2020;10(10):1406.
CAS
PubMed Central
Google Scholar
Lee JH, et al. Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma. J Adv Res. 2020;26:83–94.
PubMed Central
PubMed
Google Scholar
Archer M, Dogra N, Kyprianou N. Inflammation as a driver of prostate cancer metastasis and therapeutic resistance. Cancers. 2020;12(10):2984.
CAS
PubMed Central
Google Scholar
López-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2009;1(6–7):303–14.
PubMed Central
PubMed
Google Scholar
Puar YR, et al. Evidence for the involvement of the master transcription Factor NF-κB in cancer initiation and progression. Biomedicines. 2018;6(3):82.
Ahn KS, et al. Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J Biol Chem. 2006;281(29):19798–808.
CAS
PubMed
Google Scholar
Ashrafizadeh M, et al. MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy. Biomolecules. 2020;10(7):1040.
CAS
PubMed Central
Google Scholar
Wang Y, et al. miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3. J buon. 2020;25(4):2028–35.
PubMed
Google Scholar
Gorrab A, et al. Leptin promotes prostate cancer proliferation and migration by stimulating STAT3 pathway. Nutr Cancer. 2020:1–11. https://doi.org/10.1080/01635581.2020.1792946.
Zhang Q, et al. LOXL2 upregulation in gliomas drives Tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT. Front Oncol. 2020;10:569584.
PubMed Central
PubMed
Google Scholar
Liu W, et al. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT. J Exp Clin Cancer Res. 2018;37(1):73.
PubMed Central
PubMed
Google Scholar
Manu KA, et al. Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer. Cancer Lett. 2015;363(1):28–36.
CAS
PubMed
Google Scholar
Manu KA, et al. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products. J Mol Med (Berl). 2014;92(3):267–76.
CAS
Google Scholar
Raghunath A, et al. Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance. Cancers (Basel). 2018;10(12):481.
Monisha J, et al. NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance. Cancers (Basel). 2018;10(7):228.
Jung YY, et al. Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling Cascade. Front Pharmacol. 2018;9:531.
PubMed Central
PubMed
Google Scholar
Tieu T, et al. Patient-derived prostate Cancer explants: a clinically relevant model to assess siRNA-based nanomedicines. Adv Healthc Mater. 2021;10(6):e2001594.
PubMed
Google Scholar
Ashrafizadeh M, et al. Progress in delivery of siRNA-Based therapeutics employing nano-vehicles for treatment of prostate cancer. Bioengineering (Basel). 2020;7(3):91.
Wei L, et al. Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun. 2019;10(1):4681.
PubMed Central
PubMed
Google Scholar
Kim E, et al. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Biomaterials. 2010;31(16):4592–9.
CAS
PubMed
Google Scholar
Cristofani R, et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells. Cell Death Dis. 2018;9(9):889.
PubMed Central
PubMed
Google Scholar
Zhao Y, et al. WWOX promotes apoptosis and inhibits autophagy in paclitaxel-treated ovarian carcinoma cells. Mol Med Rep. 2021;23(2):1.
Google Scholar
Yang S, et al. MicroRNA-375 targets ATG14 to inhibit autophagy and sensitize hepatocellular carcinoma cells to Sorafenib. Onco Targets Ther. 2020;13:3557–70.
CAS
PubMed Central
PubMed
Google Scholar
Anlaş AA, Nelson CM. Soft microenvironments induce Chemoresistance by increasing autophagy downstream of integrin-linked kinase. Cancer Res. 2020;80(19):4103–13.
PubMed Central
PubMed
Google Scholar
Lin JH, et al. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells. Phytother Res. 2020;34(8):2053–66.
CAS
PubMed
Google Scholar
Dubois C, et al. Co-targeting Mitochondrial Ca (2+) Homeostasis and autophagy enhances cancer cells’ chemosensitivity. iScience. 2020;23(7):101263.
CAS
PubMed Central
PubMed
Google Scholar
Zheng W, et al. Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy. Mol Carcinog. 2020;59(6):651–60.
CAS
PubMed
Google Scholar
Chen Q, et al. ANXA6 contributes to Radioresistance by promoting autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal carcinoma. Front Cell Dev Biol. 2020;8:232.
PubMed Central
PubMed
Google Scholar
Chen H, et al. MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma. Cancer Lett. 2020;483:114–26.
CAS
PubMed
Google Scholar
Ray J, et al. miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA. Cancer Lett. 2020;473:107–17.
CAS
PubMed
Google Scholar
Chen L, et al. Identification of cofilin-1 as a novel mediator for the metastatic potentials and chemoresistance of the prostate cancer cells. Eur J Pharmacol. 2020;880:173100.
CAS
PubMed
Google Scholar
Wei Y, et al. The GATOR1 complex regulates metabolic homeostasis and the response to nutrient stress in Drosophila melanogaster. G3. 2016;6(12):3859–67.
CAS
PubMed Central
PubMed
Google Scholar
Kwak SS, et al. Amino acid-dependent NPRL2 interaction with raptor determines mTOR complex 1 activation. Cell Signal. 2016;28(2):32–41.
CAS
PubMed
Google Scholar
Dutchak PA, et al. Regulation of hematopoiesis and methionine homeostasis by mTORC1 inhibitor NPRL2. Cell Rep. 2015;12(3):371–9.
CAS
PubMed Central
PubMed
Google Scholar
Haas NB, et al. Autophagy inhibition to augment mTOR inhibition: a phase I/II trial of Everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma. Clin Cancer Res. 2019;25(7):2080–7.
CAS
PubMed Central
PubMed
Google Scholar
Rosich L, et al. Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma. Clin Cancer Res. 2012;18(19):5278–89.
CAS
PubMed
Google Scholar
Chen Z, et al. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer. Prostate. 2019;79(1):44–53.
CAS
PubMed
Google Scholar
Luo S, et al. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway. Exp Cell Res. 2020;390(2):111981.
CAS
PubMed
Google Scholar
Wang Q, et al. Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells. Int Urol Nephrol. 2018;50(4):675–86.
CAS
PubMed Central
PubMed
Google Scholar
Jin S, et al. TGF-β1 fucosylation enhances the autophagy and mitophagy via PI3K/Akt and Ras-Raf-MEK-ERK in ovarian carcinoma. Biochem Biophys Res Commun. 2020;524(4):970–6.
CAS
PubMed
Google Scholar
Yu Y, et al. Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy. Cell Biosci. 2021;11(1):7.
CAS
PubMed Central
PubMed
Google Scholar
Dong JT, Chen C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci. 2009;66(16):2691–706.
CAS
PubMed
Google Scholar
Chen C, et al. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate. 2003;55(2):81–8.
CAS
PubMed
Google Scholar
Jia X, et al. BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression. Exp Cell Res. 2021;402(1):112506.
CAS
PubMed
Google Scholar
Jia J, et al. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy. Theranostics. 2019;9(19):5464–77.
CAS
PubMed Central
PubMed
Google Scholar
Chhipa RR, Wu Y, Ip C. AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia. Cell Signal. 2011;23(9):1466–72.
CAS
PubMed Central
PubMed
Google Scholar
Raudenska M, et al. Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation. Sci Rep. 2019;9(1):1660.
PubMed Central
PubMed
Google Scholar
Gupta A, et al. Mdm2-P53 interaction inhibitor with cisplatin enhances apoptosis in Colon and Prostate Cancer cells in-vitro. Asian Pac J Cancer Prev. 2019;20(11):3341–51.
CAS
PubMed Central
PubMed
Google Scholar
Zhou P, et al. miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells. Int J Oncol. 2016;48(4):1737–48.
CAS
PubMed
Google Scholar
Jiang H, et al. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer. J Cell Biochem. 2019;120(6):8965–74.
CAS
PubMed
Google Scholar
Strappazzon F, et al. Mitochondrial BCL-2 inhibits AMBRA1-induced autophagy. EMBO J. 2011;30(7):1195–208.
CAS
PubMed Central
PubMed
Google Scholar
Fimia GM, et al. Unleashing the Ambra1-Beclin 1 complex from dynein chains: Ulk1 sets Ambra1 free to induce autophagy. Autophagy. 2011;7(1):115–7.
PubMed
Google Scholar
Liu J, et al. Ambra1 induces autophagy and desensitizes human prostate cancer cells to cisplatin. Biosci Rep. 2019;39(8).
Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604–16.
CAS
PubMed
Google Scholar
Norris JS, et al. Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Ther. 2006;13(12):1045–51.
CAS
PubMed
Google Scholar
Turner LS, et al. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide. Prostate Cancer Prostatic Dis. 2011;14(1):30–7.
CAS
PubMed
Google Scholar
Lu Y, et al. CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition. Cell Commun Signal. 2019;17(1):118.
PubMed Central
PubMed
Google Scholar
Dai Y, Sieman D. n, c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells. Onco Targets Ther. 2019;12:3519–29.
CAS
PubMed Central
PubMed
Google Scholar
Wu Z, et al. Autophagy blockade sensitizes prostate Cancer cells towards Src family kinase inhibitors. Genes Cancer. 2010;1(1):40–9.
PubMed Central
PubMed
Google Scholar
Vyas AR, et al. Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy. Cancer Res. 2013;73(19):5985–95.
CAS
PubMed Central
PubMed
Google Scholar
Yun Jung Y, et al. Fangchinoline diminishes STAT3 activation by stimulating oxidative stress and targeting SHP-1 protein in multiple myeloma model. J Adv Res. 2021;35:245-57.
Kim C, et al. β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase. Mol Carcinog. 2014;53(10):793–806.
CAS
PubMed
Google Scholar
Lee JH, et al. Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel. Oncotarget. 2015;6(8):6386–405.
PubMed Central
PubMed
Google Scholar
Lee JH, et al. Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer Lett. 2014;345(1):140–8.
CAS
PubMed
Google Scholar
Chen X, et al. Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα signaling in STK11 mutant lung cancer. Autophagy. 2020;16(4):659–71.
CAS
PubMed
Google Scholar
Garg M, et al. The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy. Med Res Rev. 2020;41(3):1291-336.
Mohan CD, et al. Targeting STAT3 signaling pathway in cancer by agents derived from mother nature. Semin Cancer Biol. 2020. https://doi.org/10.1016/j.semcancer.2020.03.016.
Hu F, et al. Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3. Cancer Lett. 2018;416:24–30.
CAS
PubMed
Google Scholar
Srinivasan M, et al. HMGB1 in hormone-related cancer: a potential therapeutic target. Horm Cancer. 2014;5(3):127–39.
CAS
PubMed
Google Scholar
Tang D, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 2010;29(38):5299–310.
CAS
PubMed Central
PubMed
Google Scholar
Lei X, et al. HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression. Cell Signal. 2020;72:109631.
CAS
PubMed
Google Scholar
Zhang YX, et al. HMGB1-mediated autophagy confers resistance to gemcitabine in hormone-independent prostate cancer cells. Oncol Lett. 2017;14(5):6285–90.
PubMed Central
PubMed
Google Scholar
Xu S, Weihua Z. Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin. Prostate. 2011;71(11):1216–24.
CAS
PubMed
Google Scholar
Boutin B, et al. Androgen deprivation and androgen receptor competition by bicalutamide induce autophagy of hormone-resistant prostate cancer cells and confer resistance to apoptosis. Prostate. 2013;73(10):1090–102.
CAS
PubMed
Google Scholar
Wang R, et al. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res. 2004;64(5):1589–94.
CAS
PubMed
Google Scholar
Wu R, et al. EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer. Oncol Rep. 2014;32(6):2657–65.
CAS
PubMed
Google Scholar
Zeng J, et al. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Theranostics. 2018;8(1):109–23.
CAS
PubMed Central
PubMed
Google Scholar
Chen J, et al. Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma. Oncogene. 2015;34(40):5114–27.
CAS
PubMed
Google Scholar
Lin JZ, et al. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy. Cancer Lett. 2020;469:481–9.
CAS
PubMed
Google Scholar
Lamoureux F, et al. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363. Clin Cancer Res. 2013;19(4):833–44.
CAS
PubMed
Google Scholar
Zhu Q, et al. Knockdown of CFTR enhances sensitivity of prostate cancer cells to cisplatin via inhibition of autophagy. Neoplasma. 2017;64(5):709–17.
CAS
PubMed
Google Scholar
Frame FM, et al. Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis. Cancer Med. 2016;5(1):61–73.
CAS
PubMed
Google Scholar
Cao C, et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 2006;66(20):10040–7.
CAS
PubMed
Google Scholar
Li XR, et al. Knockdown of FBP1 enhances radiosensitivity in prostate cancer cells by activating autophagy. Neoplasma. 2020;67(5):982–91.
CAS
PubMed
Google Scholar
Wu Y, et al. Low-frequency ultrasound enhances chemotherapy sensitivity and induces autophagy in PTX-resistant PC-3 cells via the endoplasmic reticulum stress-mediated PI3K/Akt/mTOR signaling pathway. Onco Targets Ther. 2018;11:5621–30.
CAS
PubMed Central
PubMed
Google Scholar
Qiao Y, et al. Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer. Nat Cancer. 2021;2(9):978–93.
CAS
PubMed Central
PubMed
Google Scholar
Yao B, et al. PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells. Oncotarget. 2017;8(8):13846–54.
PubMed Central
PubMed
Google Scholar
Iacona JR, Lutz CS. miR-146a-5p: expression, regulation, and functions in cancer. Wiley Interdiscip Rev RNA. 2019;10(4):e1533.
PubMed
Google Scholar
Mirzaei S, et al. Regulation of nuclear factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis? Cancer Lett. 2021;509:63–80.
CAS
PubMed
Google Scholar
Sailo BL, et al. FBXW7 in cancer: what has been unraveled thus far? Cancers (Basel). 2019;11(2):246.
Friedman RC, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
CAS
PubMed Central
PubMed
Google Scholar
Rishabh K, et al. MicroRNAs as modulators of oral tumorigenesis-a focused review. Int J Mol Sci. 2021;22(5):2561.
Abadi AJ, et al. Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers. Biomolecules. 2021;11(2):304.
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.
CAS
PubMed Central
PubMed
Google Scholar
Bayraktar R, Van Roosbroeck K. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics. Cancer Metastasis Rev. 2018;37(1):33–44.
PubMed
Google Scholar
Haneklaus M, et al. miR-223: infection, inflammation and cancer. J Intern Med. 2013;274(3):215–26.
CAS
PubMed Central
PubMed
Google Scholar
Lv P, et al. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1. Kaohsiung J Med Sci. 2020;36(6):429–40.
CAS
PubMed
Google Scholar
Ashrafizadeh M, et al. MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity. Eur J Pharmacol. 2020;892:173660.
John Clotaire DZ, et al. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells. Biochem Biophys Res Commun. 2016;472(1):194–200.
PubMed
Google Scholar
Ding HY, Qian WQ, Xu J. MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer. J buon. 2016;21(2):434–43.
PubMed
Google Scholar
Gao S, et al. MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway. Aging (Albany NY). 2018;10(8):2113–21.
CAS
Google Scholar
Lee JH, et al. Casticin-induced inhibition of cell growth and survival are mediated through the dual modulation of Akt/mTOR signaling cascade. Cancers (Basel). 2019;11(2):254.
Mohan CD, et al. Trisubstituted-Imidazoles induce apoptosis in human breast Cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway. Plos One. 2016;11(4):e0153155.
PubMed Central
PubMed
Google Scholar
Braglia L, et al. Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: still a potential druggable target? Biochim Biophys Acta Mol Cell Res. 1867;2020(9):118731.
Google Scholar
Deng R, et al. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Mol Oncol. 2021;15(1):279–98.
CAS
PubMed
Google Scholar
Zhang X, et al. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way. J Exp Clin Cancer Res. 2020;39(1):190.
CAS
PubMed Central
PubMed
Google Scholar
Singh SS, et al. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine? World J Gastroenterol. 2015;21(43):12261–73.
CAS
PubMed Central
PubMed
Google Scholar
Siveen KS, et al. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget. 2014;5(7):1897–911.
PubMed Central
PubMed
Google Scholar
Ong PS, et al. Judicious toggling of mTOR activity to combat insulin resistance and Cancer: current evidence and perspectives. Front Pharmacol. 2016;7:395.
CAS
PubMed Central
PubMed
Google Scholar
Lee GH, D’Arcangelo G. New insights into reelin-mediated signaling pathways. Front Cell Neurosci. 2016;10:122.
PubMed Central
PubMed
Google Scholar
Rui X, et al. MicroRNA-381 suppresses proliferation and invasion of prostate cancer cells through downregulation of the androgen receptor. Oncol Lett. 2019;18(2):2066–72.
CAS
PubMed Central
PubMed
Google Scholar
Liao W, Zhang Y. MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway. Life Sci. 2020;254:117672.
CAS
PubMed
Google Scholar
Li J, et al. Downregulation of N (6)-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N (6)-methyladenosine levels. Oncotarget. 2018;9(3):3752–64.
PubMed
Google Scholar
Deng J, et al. miR-493 promotes prostate cancer cells proliferation by targeting PHLPP2 and activating akt signaling pathway. Clin Lab. 2019;65(3).
Deng J, et al. MiR-493 induces cytotoxic autophagy in prostate cancer cells through regulation on PHLPP2. Curr Pharm Biotechnol. 2020;21(14):1451–6.
CAS
PubMed
Google Scholar
Nam RK, et al. Mir-139 regulates autophagy in prostate cancer cells through Beclin-1 and mTOR signaling proteins. Anticancer Res. 2020;40(12):6649–63.
CAS
PubMed
Google Scholar
Du S, et al. Circ-ZNF609 accelerates the Radioresistance of prostate Cancer cells by promoting the glycolytic metabolism through miR-501-3p/HK2 Axis. Cancer Manag Res. 2020;12:7487–99.
CAS
PubMed Central
PubMed
Google Scholar
Fan L, et al. Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells. Cell Death Dis. 2020;11(4):214.
CAS
PubMed Central
PubMed
Google Scholar
Wang W, Liu J, Wu Q. MiR-205 suppresses autophagy and enhances radiosensitivity of prostate cancer cells by targeting TP53INP1. Eur Rev Med Pharmacol Sci. 2016;20(1):92–100.
CAS
PubMed
Google Scholar
Liao H, et al. microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells. Oncol Lett. 2015;10(4):2055–62.
CAS
PubMed Central
PubMed
Google Scholar
Ling Z, et al. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer. Oncol Rep. 2017;38(3):1621–8.
CAS
PubMed
Google Scholar
Xu CG, et al. MiR-30a and miR-205 are downregulated in hypoxia and modulate radiosensitivity of prostate cancer cells by inhibiting autophagy via TP53INP1. Eur Rev Med Pharmacol Sci. 2016;20(8):1501–8.
PubMed
Google Scholar
Hu B, Jin X, Wang J. MicroRNA-212 targets mitogen-activated protein kinase 1 to inhibit Proliferation and invasion of prostate Cancer cells. Oncol Res. 2018;26(7):1093–102.
PubMed Central
PubMed
Google Scholar
Qu HW, et al. MicroRNA-212 participates in the development of prostate cancer by upregulating BMI1 via NF-κB pathway. Eur Rev Med Pharmacol Sci. 2018;22(11):3348–56.
PubMed
Google Scholar
Xu C, et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat Cell Biol. 2020;22(10):1170–9.
CAS
PubMed Central
PubMed
Google Scholar
Jang KH, Hwang Y, Kim E. PARP1 impedes SIRT1-mediated autophagy during degeneration of the retinal pigment epithelium under oxidative stress. Mol Cells. 2020;43(7):632–44.
CAS
PubMed Central
PubMed
Google Scholar
Ramalinga M, et al. MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence. Oncotarget. 2015;6(33):34446–57.
PubMed Central
PubMed
Google Scholar
Zou J, et al. VEGF-A promotes angiogenesis after acute myocardial infarction through increasing ROS production and enhancing ER stress-mediated autophagy. J Cell Physiol. 2019;234(10):17690–703.
CAS
PubMed
Google Scholar
Deegan S, et al. A close connection between the PERK and IRE arms of the UPR and the transcriptional regulation of autophagy. Biochem Biophys Res Commun. 2015;456(1):305–11.
CAS
PubMed
Google Scholar
Sohn EJ. MicroRNA 200c-3p regulates autophagy via upregulation of endoplasmic reticulum stress in PC-3 cells. Cancer Cell Int. 2018;18:2.
PubMed Central
PubMed
Google Scholar
Wu M, et al. The potential of long noncoding RNAs for precision medicine in human cancer. Cancer Lett. 2020;501:12-9.
Lim YWS, et al. The double-edged sword of H19 lncRNA: insights into cancer therapy. Cancer Lett. 2020;500:253-62.
Mishra S, et al. Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases. Cell Mol Life Sci. 2019;76(10):1947–66.
CAS
PubMed Central
PubMed
Google Scholar
Chen X, Tang FR, Arfuso F, Cai WQ, Ma Z, Yang J, Sethi G. The emerging role of long non-coding RNAs in the metastasis of hepatocellular carcinoma. Biomolecules. 2020;10(1):66.
Dinger ME, et al. Differentiating protein-coding and noncoding RNA: challenges and ambiguities. Plos Comput Biol. 2008;4(11):e1000176.
PubMed Central
PubMed
Google Scholar
Ma Z, et al. The expanding roles of long non-coding RNAs in the regulation of cancer stem cells. Int J Biochem Cell Biol. 2019;108:17–20.
CAS
PubMed
Google Scholar
Ong MS, et al. ‘Lnc’-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling. Br J Pharmacol. 2017;174(24):4684–700.
CAS
PubMed Central
PubMed
Google Scholar
Pandya G, et al. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Biochim Biophys Acta Rev Cancer. 1874;2020(2):188423.
Google Scholar
Kansara S, et al. Mechanistic involvement of long non-coding RNAs in oncotherapeutics resistance in triple-negative breast cancer. Cells. 2020;9(6):1511.
Butler AA, Webb WM, Lubin FD. Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction. Epigenomics. 2016;8(1):135–51.
CAS
PubMed Central
PubMed
Google Scholar
Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–61.
CAS
PubMed
Google Scholar
Clark MB, Mattick JS. Long noncoding RNAs in cell biology. Semin Cell Dev Biol. 2011;22:366-76. Elsevier.
Shen C, et al. Long non-coding RNAs: emerging regulators for chemo/immunotherapy resistance in cancer stem cells. Cancer Lett. 2021;500:244–52.
CAS
PubMed
Google Scholar
Pucci P, et al. LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism. Epigenomics. 2020;12(13):1123–38.
CAS
PubMed
Google Scholar
Cui R, et al. LncRNA AC245100.4 binds HSP90 to promote the proliferation of prostate cancer. Epigenomics. 2020;12(15):1257–71.
CAS
PubMed Central
PubMed
Google Scholar
Zhao Z, Liang S, Sun F. LncRNA DLX6-AS1 promotes malignant phenotype and lymph node metastasis in prostate cancer by inducing LARGE methylation. Front Oncol. 2020;10:1172.
PubMed Central
PubMed
Google Scholar
Meng XF, Liu AD, Li SL. SNHG1 promotes proliferation, invasion and EMT of prostate cancer cells through miR-195-5p. Eur Rev Med Pharmacol Sci. 2020;24(19):9880–8.
PubMed
Google Scholar
Xie M, Zhang Z, Cui Y. Long noncoding RNA SNHG1 contributes to the promotion of prostate cancer cells through regulating miR-377-3p/AKT2 Axis. Cancer Biother Radiopharm. 2020;35(2):109–19.
CAS
PubMed
Google Scholar
Chen J, et al. Long non-coding RNA SNHG1 regulates the Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol. 2020;10:552907.
PubMed Central
PubMed
Google Scholar
Fan L, Li H, Wang W. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy. Exp Physiol. 2020;105(5):793–808.
CAS
PubMed
Google Scholar
Wang C, et al. Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nat Commun. 2020;11(1):3162.
CAS
PubMed Central
PubMed
Google Scholar
Zheng P, et al. High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer. Arch Med Sci. 2018;14(3):679–86.
CAS
PubMed
Google Scholar
Chen C, et al. LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells. Braz J Med Biol Res. 2018;51(6):e7080.
PubMed Central
PubMed
Google Scholar
Meng S, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):1–8.
CAS
Google Scholar
Verduci L, et al. The circRNA–microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–80.
PubMed Central
PubMed
Google Scholar
Yin Y, et al. Emerging roles of circRNA in formation and progression of cancer. J Cancer. 2019;10(21):5015.
CAS
PubMed Central
PubMed
Google Scholar
Suzuki H, Tsukahara T. A view of pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci. 2014;15(6):9331–42.
CAS
PubMed Central
PubMed
Google Scholar
Zheng Y, et al. Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway. Biochem Cell Biol. 2020;98(3):396–404.
CAS
PubMed
Google Scholar
Li H, et al. Circ_0062020 knockdown strengthens the radiosensitivity of prostate cancer cells. Cancer Manag Res. 2020;12:11701–12.
CAS
PubMed Central
PubMed
Google Scholar
Cai F, et al. Knockdown of Circ_CCNB2 sensitizes prostate cancer to radiation through repressing autophagy by the miR-30b-5p/KIF18A Axis. Cancer Biother Radiopharm. 2020. https://doi.org/10.1089/cbr.2019.3538.
Gu H, et al. Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1. Cancer Med. 2016;5(6):1174–82.
CAS
PubMed Central
PubMed
Google Scholar
Guo YJ, Liu JX, Guan YW. Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2. Eur Rev Med Pharmacol Sci. 2016;20(1):101–8.
PubMed
Google Scholar
Ma Y, et al. Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia. Oncotarget. 2014;5(19):9169–82.
PubMed Central
PubMed
Google Scholar
Pennati M, et al. miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells. Biochem Pharmacol. 2014;87(4):579–97.
CAS
PubMed
Google Scholar
Liao H, et al. Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer. Oncol Rep. 2016;35(1):64–72.
CAS
PubMed
Google Scholar
Wang X, et al. Dysregulation of long non-coding RNA SNHG12 alters the viability, apoptosis, and autophagy of prostate cancer cells by regulating miR-195/CCNE1 axis. Int J Clin Exp Pathol. 2019;12(4):1272–83.
CAS
PubMed Central
PubMed
Google Scholar
Coffey K, et al. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res. 2013;41(8):4433–46.
CAS
PubMed Central
PubMed
Google Scholar
Yang J, Harris AL, Davidoff AM. Hypoxia and hormone-mediated pathways converge at the histone demethylase KDM4B in cancer. Int J Mol Sci. 2018;19(1):240.
PubMed Central
Google Scholar
Sha J, et al. Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy. J Cell Physiol. 2020;235(3):2129–38.
CAS
PubMed
Google Scholar
Ashrafizadeh M, et al. Resveratrol targeting the Wnt signaling pathway: a focus on therapeutic activities. J Cell Physiol. 2020;235(5):4135–45.
CAS
PubMed
Google Scholar
Lin R, et al. Regulation of autophagy of prostate cancer cells by β-catenin signaling. Cell Physiol Biochem. 2015;35(3):926–32.
CAS
PubMed
Google Scholar
Brunet A, et al. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol. 2001;21(3):952–65.
CAS
PubMed Central
PubMed
Google Scholar
Dehner M, et al. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1. J Biol Chem. 2008;283(28):19201–10.
CAS
PubMed
Google Scholar
Liu W, et al. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway. Br J Cancer. 2017;117(8):1139–53.
CAS
PubMed Central
PubMed
Google Scholar
Verheij M, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996;380(6569):75–9.
CAS
PubMed
Google Scholar
Zhao S, et al. Propranolol induced apoptosis and autophagy via the ROS/JNK signaling pathway in human ovarian Cancer. J Cancer. 2020;11(20):5900–10.
CAS
PubMed Central
PubMed
Google Scholar
Yang J, et al. Chlorpyrifos induces apoptosis and autophagy in common carp lymphocytes by influencing the TCR γ-dependent PI3K/AKT/JNK pathway. Fish Shellfish Immunol. 2020;99:587–93.
CAS
PubMed
Google Scholar
Zhu X, et al. Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosis. Exp Ther Med. 2017;13(5):2348–54.
CAS
PubMed Central
PubMed
Google Scholar
Niki T, et al. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this Complex1 1 Ministry of Education, science, sport, culture and Technology of Japan. 2 2 the nucleotide sequence reported in this paper has been submitted to the DDBJ/GenBank/EBI data Bank with accession number AB073862. Mol Cancer Res. 2003;1(4):247–61.
CAS
PubMed
Google Scholar
Takahashi K, et al. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor. J Biol Chem. 2001;276(40):37556–63.
CAS
PubMed
Google Scholar
Qin X, et al. DJ-1 inhibits autophagy activity of prostate cancer cells by repressing JNK-Bcl2-Beclin1 signaling. Cell Biol Int. 2020;44(4):937–46.
CAS
PubMed
Google Scholar
Li H, et al. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis. Oncogene. 2019;38(3):345–59.
CAS
PubMed
Google Scholar
Yu H, et al. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin Cancer Res. 2014;20(13):3434–45.
CAS
PubMed
Google Scholar
Haider R, et al. Sirtuin 7: a new marker of aggressiveness in prostate cancer. Oncotarget. 2017;8(44):77309–16.
PubMed Central
PubMed
Google Scholar
Tang X, et al. SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis. Nat Commun. 2017;8(1):318.
PubMed Central
PubMed
Google Scholar
Niture S, et al. TNFAIP8 promotes prostate cancer cell survival by inducing autophagy. Oncotarget. 2018;9(42):26884–99.
PubMed Central
PubMed
Google Scholar
Kang HY, et al. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem. 2002;277(46):43749–56.
CAS
PubMed
Google Scholar
Tektemur A, et al. TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer. J Cancer Res Clin Oncol. 2019;145(5):1297–311.
CAS
PubMed
Google Scholar
Sethi G, et al. Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review. Nutrients. 2018;10(5):645.
Zhang J, et al. Diosgenin inhibits the expression of NEDD4 in prostate cancer cells. Am J Transl Res. 2019;11(6):3461–71.
CAS
PubMed Central
PubMed
Google Scholar
Sun GC, Jan CR, Liang WZ. Exploring the impact of a naturally occurring sapogenin diosgenin on underlying mechanisms of ca (2+) movement and cytotoxicity in human prostate cancer cells. Environ Toxicol. 2020;35(3):395–403.
CAS
PubMed
Google Scholar
Nie C, et al. Diosgenin-induced autophagy and apoptosis in a human prostate cancer cell line. Mol Med Rep. 2016;14(5):4349–59.
CAS
PubMed
Google Scholar
Ma X, et al. Inhibition of autophagy improves the efficacy of Abiraterone for the treatment of prostate Cancer. Cancer Biother Radiopharm. 2019;34(3):181–8.
CAS
PubMed
Google Scholar
Riaz A, et al. Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction. Pak J Pharm Sci. 2019;32(6(Supplementary)):2843–8.
CAS
PubMed
Google Scholar
Lu YM, et al. Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway. Mol Med Rep. 2016;13(3):2235–40.
CAS
PubMed
Google Scholar
Sun HD, et al. Diterpenoids from Isodon eriocalyx var. laxiflora. Phytochemistry. 1995;38(6):1451–5.
CAS
PubMed
Google Scholar
Yu Z, Chen Y, Liang C. Eriocalyxin B induces apoptosis and autophagy involving Akt/mammalian target of rapamycin (mTOR) pathway in prostate cancer cells. Med Sci Monit. 2019;25:8534–43.
CAS
PubMed Central
PubMed
Google Scholar
Hahm ER, Singh SV. Cytoprotective autophagy induction by withaferin a in prostate cancer cells involves GABARAPL1. Mol Carcinog. 2020;59(10):1105–15.
CAS
PubMed Central
PubMed
Google Scholar
Waldvogel-Abramowski S, et al. Physiology of iron metabolism. Transfus Med Hemother. 2014;41(3):213–21.
PubMed Central
PubMed
Google Scholar
Kühn LC. Iron regulatory proteins and their role in controlling iron metabolism. Metallomics. 2015;7(2):232–43.
PubMed
Google Scholar
Zhang C, Zhang F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell. 2015;6(2):88–100.
CAS
PubMed
Google Scholar
Ba Q, et al. Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies. Clin Cancer Res. 2011;17(24):7625–33.
CAS
PubMed
Google Scholar
Pullarkat V, et al. Iron chelators induce autophagic cell death in multiple myeloma cells. Leuk Res. 2014;38(8):988–96.
CAS
PubMed
Google Scholar
Yang C, et al. Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation. Drug Des Devel Ther. 2017;11:431–9.
CAS
PubMed Central
PubMed
Google Scholar
Chen X, Zhang T, Zhang Y. Endoplasmic reticulum stress and autophagy in HIV-1-associated neurocognitive disorders. J Neurovirol. 2020:1–10. https://doi.org/10.1007/s13365-020-00906-4.
Ashrafizadeh M, et al. Therapeutic effects of kaempferol affecting autophagy and endoplasmic reticulum stress. Phytother Res. 2020;34(5):911–23.
CAS
PubMed
Google Scholar
Fontana F, et al. δ-Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells. Cell Prolif. 2019;52(3):e12576.
PubMed Central
PubMed
Google Scholar
Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 2020;77(22):4459–83.
CAS
PubMed
Google Scholar
Tochhawng L, et al. Gelsolin-cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion. Oncotarget. 2016;7(33):52832–48.